Other Species / Isoforms
  GLCCI1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MSTAsSSSSSSS
0 1
GLCCI1 (human) ___MSTAsSSSSSSS S5-p
GLCCI1 (mouse) gap -
GLCCI1 (rat) VTFLTTYCPTMLATT C25
S20-p
SQTPHPPsQRMRRsA
0 1
GLCCI1 (human) SQTPHPPsQRMRRsA S20-p
GLCCI1 (mouse) SQTPHSAPQRMRRst P16
GLCCI1 (rat) gap -
S26-p
PsQRMRRsAAGsPPA
0 3
GLCCI1 (human) PsQRMRRsAAGsPPA S26-p
GLCCI1 (mouse) APQRMRRstAGsPPA S22-p
GLCCI1 (rat) gap -
A27
sQRMRRsAAGsPPAV
0 1
GLCCI1 (human) sQRMRRsAAGsPPAV A27
GLCCI1 (mouse) PQRMRRstAGsPPAA T23-p
GLCCI1 (rat) gap -
S30-p
MRRsAAGsPPAVAAA
0 12
GLCCI1 (human) MRRsAAGsPPAVAAA S30-p
GLCCI1 (mouse) MRRstAGsPPAAAGS S26-p
GLCCI1 (rat) gap -
T67-p
LLQPIRAtVPyQLLr
0 1
GLCCI1 (human) LLQPIRAtVPyQLLr T67-p
GLCCI1 (mouse) LLQPIRATVPYQLLR T57
GLCCI1 (rat) gap -
Y70-p
PIRAtVPyQLLrGsQ
0 4
GLCCI1 (human) PIRAtVPyQLLrGsQ Y70-p
GLCCI1 (mouse) PIRATVPYQLLRGSQ Y60
GLCCI1 (rat) gap -
R74-m1
tVPyQLLrGsQHsPt
0 1
GLCCI1 (human) tVPyQLLrGsQHsPt R74-m1
GLCCI1 (mouse) TVPYQLLRGSQHsPT R64
GLCCI1 (rat) gap -
S76-p
PyQLLrGsQHsPtrP
Upstream
0 1
Treatment
  • MLN8054
GLCCI1 (human) PyQLLrGsQHsPtrP S76-p
GLCCI1 (mouse) PYQLLRGSQHsPTRP S66
GLCCI1 (rat) gap -
S79-p
LLrGsQHsPtrPPVA
Upstream
0 5
Treatment
  • EGF
GLCCI1 (human) LLrGsQHsPtrPPVA S79-p
GLCCI1 (mouse) LLRGSQHsPTRPAAA S69-p
GLCCI1 (rat) gap -
T81-p
rGsQHsPtrPPVAAA
0 2
GLCCI1 (human) rGsQHsPtrPPVAAA T81-p
GLCCI1 (mouse) RGSQHsPTRPAAAAT T71
GLCCI1 (rat) gap -
R82-m1
GsQHsPtrPPVAAAA
0 1
GLCCI1 (human) GsQHsPtrPPVAAAA R82-m1
GLCCI1 (mouse) GSQHsPTRPAAAATA R72
GLCCI1 (rat) gap -
R102-m1
LPGPGAArGPsPssP
0 1
GLCCI1 (human) LPGPGAArGPsPssP R102-m1
GLCCI1 (mouse) LSGPGGARGPsPssP R93
GLCCI1 (rat) gap -
S105-p
PGAArGPsPssPtPP
Upstream
0 26
Treatment
  • nocodazole
GLCCI1 (human) PGAArGPsPssPtPP S105-p
GLCCI1 (mouse) PGGARGPsPssPtPP S96-p
GLCCI1 (rat) gap -
S107-p
AArGPsPssPtPPAA
0 4
GLCCI1 (human) AArGPsPssPtPPAA S107-p
GLCCI1 (mouse) GARGPsPssPtPPPA S98-p
GLCCI1 (rat) gap -
S108-p
ArGPsPssPtPPAAA
0 27
GLCCI1 (human) ArGPsPssPtPPAAA S108-p
GLCCI1 (mouse) ARGPsPssPtPPPAA S99-p
GLCCI1 (rat) gap -
T110-p
GPsPssPtPPAAAAP
0 9
GLCCI1 (human) GPsPssPtPPAAAAP T110-p
GLCCI1 (mouse) GPsPssPtPPPAAAP T101-p
GLCCI1 (rat) gap -
S131-p
AKGRPRRsPESHRRS
0 2
GLCCI1 (human) AKGRPRRsPESHRRS S131-p
GLCCI1 (mouse) AKGRPRRSPEsRRRS S122
GLCCI1 (rat) gap -
S134
RPRRsPESHRRSSsP
0 1
GLCCI1 (human) RPRRsPESHRRSSsP S134
GLCCI1 (mouse) RPRRSPEsRRRSSsP S125-p
GLCCI1 (rat) gap -
S140-p
ESHRRSSsPERRsPG
0 2
GLCCI1 (human) ESHRRSSsPERRsPG S140-p
GLCCI1 (mouse) EsRRRSSsPERRsPG S131-p
GLCCI1 (rat) gap -
S145-p
SSsPERRsPGsPVCR
0 16
GLCCI1 (human) SSsPERRsPGsPVCR S145-p
GLCCI1 (mouse) SSsPERRsPGsPVCR S136-p
GLCCI1 (rat) gap -
S148-p
PERRsPGsPVCRADK
0 15
GLCCI1 (human) PERRsPGsPVCRADK S148-p
GLCCI1 (mouse) PERRsPGsPVCRVDR S139-p
GLCCI1 (rat) gap -
K157-m1
VCRADKAksQQVRTS
0 1
GLCCI1 (human) VCRADKAksQQVRTS K157-m1
GLCCI1 (mouse) VCRVDRPKsQHIRTS K148
GLCCI1 (rat) PDSVDRPKSQQIRNS K41
S158-p
CRADKAksQQVRTSS
0 2
GLCCI1 (human) CRADKAksQQVRTSS S158-p
GLCCI1 (mouse) CRVDRPKsQHIRTSS S149-p
GLCCI1 (rat) DSVDRPKSQQIRNSS S42
T170-p
TSSTIRRtssLDtIt
0 6
GLCCI1 (human) TSSTIRRtssLDtIt T170-p
GLCCI1 (mouse) TSSTIRRTSsLDtIt T161
GLCCI1 (rat) NSSTIRRTSSLDTIT T54
S171-p
SSTIRRtssLDtItG
0 6
GLCCI1 (human) SSTIRRtssLDtItG S171-p
GLCCI1 (mouse) SSTIRRTSsLDtItG S162
GLCCI1 (rat) SSTIRRTSSLDTITG S55
S172-p
STIRRtssLDtItGP
0 18
GLCCI1 (human) STIRRtssLDtItGP S172-p
GLCCI1 (mouse) STIRRTSsLDtItGP S163-p
GLCCI1 (rat) STIRRTSSLDTITGP S56
T175-p
RRtssLDtItGPYLT
Upstream
0 8
Treatment
  • anti-CD3
GLCCI1 (human) RRtssLDtItGPYLT T175-p
GLCCI1 (mouse) RRTSsLDtItGPyLt T166-p
GLCCI1 (rat) RRTSSLDTITGPYLT T59
T177-p
tssLDtItGPYLTGQ
0 5
GLCCI1 (human) tssLDtItGPYLTGQ T177-p
GLCCI1 (mouse) TSsLDtItGPyLtGQ T168-p
GLCCI1 (rat) TSSLDTITGPYLTGQ T61
Y180
LDtItGPYLTGQWPR
0 1
GLCCI1 (human) LDtItGPYLTGQWPR Y180
GLCCI1 (mouse) LDtItGPyLtGQWPR Y171-p
GLCCI1 (rat) LDTITGPYLTGQWPR Y64
T182
tItGPYLTGQWPRDP
0 1
GLCCI1 (human) tItGPYLTGQWPRDP T182
GLCCI1 (mouse) tItGPyLtGQWPRDP T173-p
GLCCI1 (rat) TITGPYLTGQWPRDP T66
S221-p
EKRSHQRsAsWGSAD
0 4
GLCCI1 (human) EKRSHQRsAsWGSAD S221-p
GLCCI1 (mouse) EKRSHQRsAsWGSAD S212-p
GLCCI1 (rat) EKRSHQRSAsWGSAD S105
S223-p
RSHQRsAsWGSADQL
0 51
GLCCI1 (human) RSHQRsAsWGSADQL S223-p
GLCCI1 (mouse) RSHQRsAsWGSADQL S214-p
GLCCI1 (rat) RSHQRSAsWGSADQL S107-p
S258-p
SKEKDRQsPLHGNHI
0 49
GLCCI1 (human) SKEKDRQsPLHGNHI S258-p
GLCCI1 (mouse) SKEKDRQsPLHGNHI S248-p
GLCCI1 (rat) SREKDRQSPLHGNHI S141
T266-p
PLHGNHItISHTQAT
0 1
GLCCI1 (human) PLHGNHItISHTQAT T266-p
GLCCI1 (mouse) PLHGNHITISHTQAI T256
GLCCI1 (rat) PLHGNHIPISHTQAI P149
S277-p
TQATGSRsVPMPLSN
Upstream
0 5
Treatment
  • ischemia
GLCCI1 (human) TQATGSRsVPMPLSN S277-p
GLCCI1 (mouse) TQAIGSRsVPMPLSN S267-p
GLCCI1 (rat) TQAIGSRSVPMPLSN S160
S303-p
PCNVEGIsPELEKVF
0 31
GLCCI1 (human) PCNVEGIsPELEKVF S303-p
GLCCI1 (mouse) PCNVEGIsPELEKVF S293-p
GLCCI1 (rat) PCNVEGIsPELEKVF S186-p
K317-ac
FIKENNGkEEVSKPL
0 2
GLCCI1 (human) FIKENNGkEEVSKPL K317-ac
GLCCI1 (mouse) FIKENNGKEEVSKPL K307
GLCCI1 (rat) FIKENNGKEEVSKPL K200
S340-p
PLPAHYRssstRsID
0 2
GLCCI1 (human) PLPAHYRssstRsID S340-p
GLCCI1 (mouse) PLPAHYRSSstRsID S330
GLCCI1 (rat) PLPAHYRSSSTRsID S223
S341-p
LPAHYRssstRsIDT
0 3
GLCCI1 (human) LPAHYRssstRsIDT S341-p
GLCCI1 (mouse) LPAHYRSSstRsIDt S331
GLCCI1 (rat) LPAHYRSSSTRsIDT S224
S342-p
PAHYRssstRsIDTQ
0 11
GLCCI1 (human) PAHYRssstRsIDTQ S342-p
GLCCI1 (mouse) PAHYRSSstRsIDtQ S332-p
GLCCI1 (rat) PAHYRSSSTRsIDTQ S225
T343-p
AHYRssstRsIDTQt
0 7
GLCCI1 (human) AHYRssstRsIDTQt T343-p
GLCCI1 (mouse) AHYRSSstRsIDtQt T333-p
GLCCI1 (rat) AHYRSSSTRsIDTQt T226
S345-p
YRssstRsIDTQtPS
0 42
GLCCI1 (human) YRssstRsIDTQtPS S345-p
GLCCI1 (mouse) YRSSstRsIDtQtPs S335-p
GLCCI1 (rat) YRSSSTRsIDTQtPS S228-p
T348
sstRsIDTQtPSVQE
0 1
GLCCI1 (human) sstRsIDTQtPSVQE T348
GLCCI1 (mouse) SstRsIDtQtPsVQE T338-p
GLCCI1 (rat) SSTRsIDTQtPSVQE T231
T350-p
tRsIDTQtPSVQERS
0 26
GLCCI1 (human) tRsIDTQtPSVQERS T350-p
GLCCI1 (mouse) tRsIDtQtPsVQERS T340-p
GLCCI1 (rat) TRsIDTQtPSVQERS T233-p
S352
sIDTQtPSVQERSSS
0 2
GLCCI1 (human) sIDTQtPSVQERSSS S352
GLCCI1 (mouse) sIDtQtPsVQERSSS S342-p
GLCCI1 (rat) sIDTQtPSVQERSSS S235
S394
LYDRDKDSGsSsPLP
0 4
GLCCI1 (human) LYDRDKDSGsSsPLP S394
GLCCI1 (mouse) LYDRDKDsGsSsPLP S384-p
GLCCI1 (rat) LYDRDKDSGSSSPLP S277
S396-p
DRDKDSGsSsPLPKY
0 3
GLCCI1 (human) DRDKDSGsSsPLPKY S396-p
GLCCI1 (mouse) DRDKDsGsSsPLPKy S386-p
GLCCI1 (rat) DRDKDSGSSSPLPKY S279
S398-p
DKDSGsSsPLPKYAs
0 10
GLCCI1 (human) DKDSGsSsPLPKYAs S398-p
GLCCI1 (mouse) DKDsGsSsPLPKyAS S388-p
GLCCI1 (rat) DKDSGSSSPLPKYAS S281
Y403
sSsPLPKYAssPKPN
0 1
GLCCI1 (human) sSsPLPKYAssPKPN Y403
GLCCI1 (mouse) sSsPLPKyASsPKPN Y393-p
GLCCI1 (rat) SSSPLPKYASSPKPN Y286
S405-p
sPLPKYAssPKPNNS
0 1
GLCCI1 (human) sPLPKYAssPKPNNS S405-p
GLCCI1 (mouse) sPLPKyASsPKPNNs S395
GLCCI1 (rat) SPLPKYASSPKPNNS S288
S406-p
PLPKYAssPKPNNSY
0 9
GLCCI1 (human) PLPKYAssPKPNNSY S406-p
GLCCI1 (mouse) PLPKyASsPKPNNsY S396-p
GLCCI1 (rat) PLPKYASSPKPNNSY S289
S412
ssPKPNNSYMFKREP
0 1
GLCCI1 (human) ssPKPNNSYMFKREP S412
GLCCI1 (mouse) SsPKPNNsYMFKREP S402-p
GLCCI1 (rat) SSPKPNNSYMFKREP S295
K427-ub
PEGCERVkVFEEMAS
0 1
GLCCI1 (human) PEGCERVkVFEEMAS K427-ub
GLCCI1 (mouse) PEGCERVKVFEEMAS K417
GLCCI1 (rat) PEGCERVKVFEEMAS K310
S480-p
SDLMLKNsPNsGQSS
Upstream
0 5
Treatment
  • nocodazole
GLCCI1 (human) SDLMLKNsPNsGQSS S480-p
GLCCI1 (mouse) SDLMLKNsPNSGQSS S470-p
GLCCI1 (rat) SDLMLKNSPNSGQSS S363
S483-p
MLKNsPNsGQSSALA
0 1
GLCCI1 (human) MLKNsPNsGQSSALA S483-p
GLCCI1 (mouse) MLKNsPNSGQSSALA S473
GLCCI1 (rat) MLKNSPNSGQSSALA S366